Todd C. Brady, President and CEO at Aldeyra Therapeutics, Inc. (ALDX), bought 12,500 shares at $8.00 ($100K) on 2014-05-07, disclosed to the SEC on 2014-05-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALDX | BUY | 2022-06-27 | $59K | — | Filing → |
| ALDX | BUY | 2019-12-18 | $102K | — | Filing → |
| ALDX | BUY | 2019-10-02 | $49K | — | Filing → |